Vimarsana
Biggest News Aggregation in the World

Professor Mark Jit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Professor Mark Jit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Professor Mark Jit Today - Breaking & Trending Today

Expert Comment – Vaccines have saved more than 150 million lives - Vimarsana News

Expert Comment – Vaccines have saved more than 150 million lives

The Expanded Programme on Immunisation (EPI) has saved 154 million lives over the last 50 years – equivalent to six lives saved every minute of every year – according to a study published in The Lancet.

Mark Jit elected a Fellow of the Academy of Medical Sciences - Vimarsana News

Mark Jit elected a Fellow of the Academy of Medical Sciences

Professor Mark Jit from the London School of Hygiene & Tropical Medicine (LSHTM) has been elected as a Fellow of the Academy of Medical Sciences this year. Professor Jit, a professor of vaccine epidemiology and head of the department of infectious disease epidemiology, is one of 59 influential biomedical and health scientists who have been awarded the prestigious fellowship. Fellows were chosen from 353 candidates from UK institutions, with their research expertise spanning from molecular imaging to biostatistics and public health policy.  

Is Covid really over? WHO's announcement sounds more like surrender than victory | Coronavirus - Vimarsana News

Is Covid really over? WHO's announcement sounds more like surrender than victory | Coronavirus

Although the acute phase of the pandemic may be over, experts agree that the virus’s effects will remain profound

<i>The Lancet</i>: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout - Vimarsana News

<i>The Lancet</i>: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout

Peer-reviewed / Review, Survey and Opinion piece To ensure an effective global immunisation strategy against COVID-19, vaccines need to be produced at scale, priced affordably, and allocated globally so that they are available where needed, and successfully rolled out. Review of evidence includes a comparison of 26 leading vaccines on their potential contribution to achieving global vaccine immunity, and a new survey of COVID-19 vaccine confidence in 32 countries. Having new COVID-19 vaccines will mean little if people around the world are unable to get vaccinated in a timely manner. Vaccine...

From production to pricing: Can the world meet COVID-19 vaccination challenges? - Vimarsana News

From production to pricing: Can the world meet COVID-19 vaccination challenges?

Vaccines must be affordable and available to all countries say the authors of a Health Policy piece published in The Lancet. The authors also stress that governments must have the administrative and political capacities to deliver them locally to ensure an effective global immunisation strategy against COVID-19.